Cargando…
Prognostic Impact of Dihydropyrimidine Dehydrogenase Germline Variants in Unresectable Non-Small Cell Lung Cancer Patients Treated with Platin-Based Chemotherapy
Platin-based chemotherapy is the standard treatment for patients with non-small cell lung cancer (NSCLC). However, resistance to this therapy is a major obstacle in successful treatment. In this study, we aimed to investigate the impact of several pharmacogenetic variants in patients with unresectab...
Autores principales: | Guijarro-Eguinoa, Javier, Arjona-Hernandez, Sara, Stewart, Stefan, Pernia, Olga, Arias, Pedro, Losantos-García, Itsaso, Rubio, Tania, Burdiel, Miranda, Rodriguez-Antolin, Carlos, Cruz-Castellanos, Patricia, Higuera, Oliver, Borobia, Alberto M., Rodriguez-Novoa, Sonia, de Castro-Carpeño, Javier, Ibanez de Caceres, Inmaculada, Rosas-Alonso, Rocio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298094/ https://www.ncbi.nlm.nih.gov/pubmed/37372990 http://dx.doi.org/10.3390/ijms24129843 |
Ejemplares similares
-
miR-124 as a Liquid Biopsy Prognostic Biomarker in Small Extracellular Vesicles from NSCLC Patients
por: Sanchez-Cabrero, Darío, et al.
Publicado: (2023) -
miR-7 methylation as a biomarker to predict poor survival in early-stage non-small cell lung cancer patients
por: Rodríguez-Antolín, Carlos, et al.
Publicado: (2019) -
MiR-151a: a robust endogenous control for normalizing small extracellular vesicle cargo in human cancer
por: Burdiel, Miranda, et al.
Publicado: (2023) -
Clinical validation of a novel quantitative assay for the detection of MGMT methylation in glioblastoma patients
por: Rosas-Alonso, Rocio, et al.
Publicado: (2021) -
Advancing pharmacogenetic testing in a tertiary hospital: a retrospective analysis after 10 years of activity
por: Stewart, Stefan, et al.
Publicado: (2023)